C. Pasquier , P.-Y. Bello , P. Gourney , J. Puel , J. Izopet
{"title":"A new generation of serum anti-HIV antibody immunocapture assay for saliva testing","authors":"C. Pasquier , P.-Y. Bello , P. Gourney , J. Puel , J. Izopet","doi":"10.1016/S0928-0197(97)00024-X","DOIUrl":null,"url":null,"abstract":"<div><p><strong>Background:</strong> Epidemiological studies need easier tools to evaluate HIV prevalence, particularly in high-risk groups under difficult field conditions. Testing saliva antibody with accurate immunoassay could serve as an alternative to serum testing.</p><p><strong>Objectives:</strong> To evaluate performances on saliva of a novel commercially available assay for anti-HIV antibody.</p><p><strong>Study design:</strong> Samples of saliva from 530 patients were tested for the presence of HIV antibodies with a third generation commercially available serum-screening kit and the use of a sample diluent adapted to saliva.</p><p><strong>Results:</strong> Compared with serum sampling the sensitivity and specificity of oral sampling were respectively, 100 and 99.8%.</p><p><strong>Conclusion:</strong> The ICE HIV-1.0.2 assay used on saliva could be an efficient and non-invasive epidemiological tool for HIV testing.</p></div>","PeriodicalId":79479,"journal":{"name":"Clinical and diagnostic virology","volume":"8 3","pages":"Pages 195-197"},"PeriodicalIF":0.0000,"publicationDate":"1997-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S0928-0197(97)00024-X","citationCount":"8","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical and diagnostic virology","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S092801979700024X","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 8
Abstract
Background: Epidemiological studies need easier tools to evaluate HIV prevalence, particularly in high-risk groups under difficult field conditions. Testing saliva antibody with accurate immunoassay could serve as an alternative to serum testing.
Objectives: To evaluate performances on saliva of a novel commercially available assay for anti-HIV antibody.
Study design: Samples of saliva from 530 patients were tested for the presence of HIV antibodies with a third generation commercially available serum-screening kit and the use of a sample diluent adapted to saliva.
Results: Compared with serum sampling the sensitivity and specificity of oral sampling were respectively, 100 and 99.8%.
Conclusion: The ICE HIV-1.0.2 assay used on saliva could be an efficient and non-invasive epidemiological tool for HIV testing.